Technology & ScienceNVIDIA Locks In Eli Lilly and Thermo Fisher as BioNeMo Becomes Global Pharma AI BackboneSalvado•May 1, 2026
Technology & InnovationNVIDIA Secures Thermo Fisher and Eli Lilly as Global Biotech AI Platform Race IntensifiesSalvado•Apr 29, 2026
Healthcare TechnologyNVIDIA Secures Eli Lilly and Thermo Fisher for BioNeMo Drug Discovery Platform as Pharma AI Infrastructure ConsolidatesSalvado•Apr 17, 2026
Health & MedicineNVIDIA's BioNeMo Platform Reaches Eli Lilly and Thermo Fisher in Global Pharma AI PushSalvado•Apr 13, 2026
biotechnologyNVIDIA BioNeMo Wins Lilly, Thermo Fisher Deals as Global Biotech AI Platform Race AcceleratesSalvado•Apr 12, 2026
BusinessNVIDIA Secures Thermo Fisher, Eli Lilly Partnerships for BioNeMo Drug Discovery PlatformSalvado•Apr 10, 2026
HealthNVIDIA's BioNeMo Platform Gains Pharmaceutical Industry Adoption from US to EuropeSalvado•Apr 10, 2026
biotechnologyNVIDIA BioNeMo Secures Eli Lilly and Thermo Fisher as Platform Wars Erupt in Global Pharma AISalvado•Apr 9, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Deployed by Global Pharma Giants for AI Drug Discovery in 2026Salvado•Apr 9, 2026
Healthcare AINVIDIA BioNeMo Platform Secures Eli Lilly and Thermo Fisher Partnerships for AI Drug Discovery InfrastructureSalvado•Mar 26, 2026
Healthcare TechnologyNVIDIA's AI Platform Powers Drug Discovery at Thermo Fisher, Eli Lilly in $1.6 Trillion Pharma Market PushSalvado•Mar 25, 2026
BiotechNVIDIA BioNeMo Platform Gains Thermo Fisher and Eli Lilly Adoption as Biological AI Market ExpandsSalvado•Mar 22, 2026
Science & TechnologyNVIDIA's BioNeMo Aims to Become the Global Infrastructure Layer for Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Science & TechnologyNVIDIA's BioNeMo Positions AI as the New Global Lab Infrastructure in Race to Reinvent Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Science & TechnologyNVIDIA's BioNeMo Bets on Becoming the Global Infrastructure Layer for Pharmaceutical AIViaNews Editorial Team•Feb 18, 2026
